The UK Intellectual Property Office (UKIPO) is consulting on possible changes to the UK design framework with the aims of improving design validity, simplifying the regime, and protecting emerging forms of design.
READ MOREAs many in the life sciences and chemical sectors await the G2/21 decision, Jonathan Bailey, Associate in the Dehns Chemical Group, discusses how much experimental data is needed for patent applications in Europe.
Invention harvesting, or invention mining, is an important process for any company looking to build or expand a patent portfolio.
In the second episode of The IP Podcast’s UPC special, Dehns Partner Mark Bell discusses what factors people need to consider when deciding on the best course of action for their patent, patents or patent applications, including:
All these questions and more, answered in less than 30 minutes!
Plant Variety Rights (PVRs), also known as Plant Breeders’ Rights (PBRs), are an important form of intellectual property for plant breeders seeking protection for their investment in the generation of a new variety of plant. As many patent offices, including the European Patent Office (EPO) and UK Intellectual Property Office (UKIPO), have provisions that exclude individual plant varieties from patent protection, PVRs represent a valuable asset for plant breeders in many countries.
Methods for treatment of the human or animal body by therapy (or surgery) are excluded from patent protection at the EPO under Article 53(c) EPC. The purpose of the exclusion is to avoid restricting the activities of medical and veterinary practitioners. In contrast, purely non-therapeutic methods of treatment, e.g. purely cosmetic methods, are permitted.
On face value, the EPO’s approach seems clear and navigable. However, in practice the waters are murkier.
In this episode of The IP Podcast, Dehns Partner Mark Bell looks at a major topic in the IP world, and certainly the biggest and most significant change to the European Patent system for nearly 50 years – the introduction of the Unified Patent Court and the Unitary Patent.
Cadbury finally hits a purple patch: Paul Harris, Head of Litigation at Dehns, provides a case analysis of Nestlé v Cadbury.
In this article, Joseph Letang, Partner in the Dehns Trade Marks Group, warns against claiming rights in descriptive terms.
This webinar covers filing priority applications, inventors and owners, the international (PCT) patent application process and filing foreign patent applications.
In the first episode of Season 2 of The IP Podcast, Dehns Partner Tim Wilson takes a look at NFTs and the main IP issues surrounding them.
Subscribe here for updates on IP news, events and webinars.
|